Evaluation of the Cost-Utility of the York Faecal Calprotectin Care Pathway.

Conclusions: The YFCCP demonstrated a QALY benefit when compared with all alternative pathways. PMID: 32249622 [PubMed - as supplied by publisher]
Source: Expert Review of Pharmacoeconomics and Outcomes Research - Category: Health Management Tags: Expert Rev Pharmacoecon Outcomes Res Source Type: research